NCT02993328 - A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Plaque Psoriasis in Adults | Biotech Hunter

Timeline

Start Date

June 10, 2018

Primary Completion Date

January 1, 2019

Study Completion Date

January 1, 2019

Conditions

Plaque Psoriasis

Interventions

DRUG

SAN021 Serum

SAN021 is a serum containing 10% East Indian Sandalwood Oil. It is packaged in an amber glass bottle with a dropper top. The dose is 5 drops per 1% BSA involvement twice daily.

DRUG

SAN021 Placebo

SAN021 Placebo is a serum that does not contain East Indian Sandalwood Oil however, does contain a synthetic sandalwood fragrance. It is packaged in an amber glass bottle with a dropper top. The dose is 5 drops per 1% BSA involvement twice daily.

Trial Locations (1)

6160

Dermatology West, Fremantle